Episode 1683: Andrew Huberman | The Brogan Report

Introduction

Episode 1683 of the Joe Rogan Experience, featuring neuroscientist Dr. Andrew Huberman, aired on July 14, 2021. Huberman is a tenured Associate Professor of Neurobiology and Ophthalmology at Stanford University School of Medicine, with a legitimate and accomplished research career in vision science. He has published over 75 peer-reviewed articles in top journals and received prestigious awards including the Cogan Award for contributions to ophthalmology.

However, this nearly three-hour episode is problematic because Huberman ventures far outside his area of expertise — vision science and neural development — to make specific supplement recommendations with dosages for products that have no human clinical trials, documented toxicity in animal studies, and significant financial conflicts of interest. When a credentialed Stanford professor makes specific health recommendations to an audience of millions, the potential for real-world harm is substantial, particularly when those recommendations involve unregulated supplements with known safety concerns.

The Guest’s Background

Andrew Huberman holds legitimate credentials in neuroscience:

Ph.D. in Neuroscience from UC Davis (2004), with the Allan G. Marr Prize for Best Dissertation
Tenured Associate Professor of Neurobiology and Ophthalmology at Stanford University School of Medicine
75+ peer-reviewed publications in journals including Nature, Science, and Cell
H-index of 45 with over 14,000 citations
Research focus: Visual system development, neural plasticity, and brain states affecting perception

Critical distinction: Huberman’s published research is in vision science and neural circuit development — not in endocrinology, supplement pharmacology, testosterone optimization, or gut microbiome science. His recommendations in these areas, while delivered with the authority of a Stanford professor, fall outside his demonstrated research expertise.

Sources: Stanford Profiles - Andrew Huberman; Stanford Medicine - Andrew Huberman

Key Problematic Claims

Claim: Fadogia Agrestis Boosts Testosterone and “Makes the Testes Grow”

Huberman recommended Fadogia agrestis as a testosterone-boosting supplement at doses of 300-600 mg per day, claiming it “actually makes the testes grow” and that most people see “about a 300 to 400 point increase” in testosterone. He presented this to Rogan’s audience as a viable alternative for athletes who cannot use anabolic compounds.

Fact-Check: There are zero published human clinical trials on Fadogia agrestis. Every claim about its effects in humans is extrapolated from rodent studies or anecdotal reports. The only published research involves rats, and those studies actually raise serious safety concerns:

A 2005 study in the Asian Journal of Andrology found that while aqueous extract of Fadogia agrestis showed aphrodisiac properties in rats, it also caused “alterations brought about by the aqueous extract [that] are indications of adverse effects on male rat testicular function.”
A 2007 study published in Journal of Ethnopharmacology documented disruption to liver and kidney enzymes in rats.
A 2023 study in Scientific African reported “massive inflammation of the kidneys and death of liver tissues” at doses with a human equivalent of approximately 607 mg for a 75 kg adult — within the range Huberman recommends.
Significant increases in serum malondialdehyde (a marker of oxidative stress and cellular damage) were found across all treated groups.

No human study has established what a safe or effective dose looks like. Huberman’s claim of “300 to 400 point” testosterone increases is not supported by any published clinical data.

Sources: PubMed - Fadogia agrestis aphrodisiac potentials; PubMed - Fadogia agrestis effects on testicular function; Examine.com - Fadogia Agrestis; WebMD - Fadogia Agrestis

Claim: Tongkat Ali Is an Effective Testosterone Booster

Huberman recommended tongkat ali (Eurycoma longifolia) for testosterone optimization, a supplement manufactured by Momentous — a company he has a financial sponsorship relationship with. He did not adequately disclose this conflict of interest during the episode.

Fact-Check: While tongkat ali has somewhat more research behind it than Fadogia agrestis, there are significant issues with Huberman’s presentation:

Huberman has claimed Indonesian tongkat ali is superior, yet the meta-analysis he cites used Malaysian tongkat ali in eight out of nine studies.
Momentous, his sponsor, uses a generic, unextracted, non-standardized Indonesian tongkat ali — unlike the patented, highly standardized Malaysian extract used in the clinical trials.
Huberman has never published any research study on tongkat ali and has no expertise in herbal pharmacology.
The financial relationship between Huberman and Momentous creates a conflict of interest that was not transparently disclosed during this JRE appearance.

Sources: CHOQ - Why Andrew Huberman Is Dead Wrong About Indonesian Tongkat Ali; McGill University Office for Science and Society - Andrew Huberman Has Supplements on the Brain

Claim: Melatonin Should Be Avoided Due to Hormonal Effects

Huberman advised against melatonin supplementation, claiming it “suppresses puberty” and has “negative effects on sex hormones,” recommending instead a supplement stack of magnesium threonate (300-400 mg), L-theanine (200-400 mg), and apigenin (50 mg) taken before sleep.

Fact-Check: Multiple sleep researchers and experts have challenged Huberman’s claims about melatonin:

His assertion that melatonin does not help with sleep maintenance has been contradicted by several literature reviews.
The claim that melatonin supplementation only adds 3.9 minutes of total sleep is a selective reading of the evidence. Multiple meta-analyses show more significant effects, particularly for people with sleep disorders.
His concerns about melatonin and puberty are based on animal studies and have not been demonstrated to be clinically significant at standard supplementation doses in adults.
Critics note that Huberman’s argument against melatonin due to variable dosing in supplements (some brands contain inaccurate amounts) is an argument for finding quality brands, not for avoiding melatonin entirely — especially when he then recommends other supplements from the same poorly regulated industry.

While Huberman’s recommended alternatives (magnesium, theanine, apigenin) are generally considered safe, presenting them as clearly superior to melatonin overstates the evidence.

Sources: CHOQ - Why Andrew Huberman’s Wrong About Melatonin; YouTube - Andrew Huberman Is Wrong About Melatonin - Breaking Down Studies

Broader Pattern: Supplements Beyond Expertise

This episode exemplifies a broader concern raised by scientists and science communicators about Huberman’s podcast content: a credentialed neuroscientist leveraging his academic authority to make health recommendations in fields far outside his research expertise.

Jonathan Jarry of McGill University’s Office for Science and Society wrote: “When a respectable neuroscientist starts sanctioning mountains of dietary supplements,” his ability to properly evaluate the literature on “these poorly regulated concoctions” is questionable.

A 2024 article in Slate by science journalist Laura Helmuth noted: “Scientists like me knew there was something amiss with Andrew Huberman’s wildly popular podcast.” The criticism centers on Huberman’s tendency to present preliminary findings — often from small, short-term studies with significant limitations — as established science.

Sources: McGill University OSS - Andrew Huberman Has Supplements on the Brain; Slate - Scientists Like Me Knew There Was Something Amiss

Financial Conflicts of Interest

A critical issue that went undisclosed or under-disclosed during this JRE appearance is Huberman’s extensive financial relationships with supplement companies:

Momentous: Huberman’s primary supplement partner, which manufactures the tongkat ali and other supplements he recommends. Estimates suggest he earns millions annually from these partnerships.
Athletic Greens (AG1): A long-time sponsor of Huberman Lab, a supplement product that costs $79/month and whose efficacy claims have been questioned by independent scientists.
These financial relationships create a structural incentive to recommend supplements, which Huberman did extensively during this episode.

When a Stanford professor recommends specific supplements to millions of listeners without clearly disclosing that he profits financially from those recommendations, it undermines the trust that his academic credentials inspire.

Sources: Slate - Andrew Huberman Podcast Debunk; McGill University OSS

Joe Rogan’s Role

Rogan’s role in this episode is that of an enthusiastic and uncritical amplifier. Rather than questioning Huberman’s supplement recommendations or asking about conflicts of interest, Rogan:

Accepted all claims without skepticism: When Huberman made specific claims about Fadogia agrestis “making the testes grow” and boosting testosterone by 300-400 points, Rogan did not ask to see the research or whether human trials existed.
Contributed his own misinformation: Rogan made claims about mRNA vaccines being “gene therapy” during this period of his podcast (a claim PolitiFact rated False), reflecting his broader pattern of COVID-era misinformation.
Failed to ask about conflicts of interest: Rogan did not question whether Huberman had financial relationships with the supplement companies whose products he was recommending.
Amplified the authority appeal: By repeatedly referencing Huberman’s Stanford credentials, Rogan helped create the impression that these supplement recommendations carried the weight of Stanford-level research, when in fact they were outside Huberman’s field of expertise.

Source: PolitiFact - Joe Rogan falsely says mRNA vaccines are ‘gene therapy’

Real-World Harm

The potential for harm from this episode is significant:

Fadogia agrestis sales surged after Huberman’s JRE appearances. Supplement companies began marketing Fadogia agrestis products at doses of 1,000-1,600 mg per serving — far exceeding even Huberman’s recommended range and well into the territory where animal studies showed organ damage.
No human safety data exists for Fadogia agrestis at any dose. Listeners who followed this advice became, in effect, unmonitored human test subjects for a supplement with documented toxicity in animals.
The supplement industry is unregulated: As the FDA does not require pre-market approval for dietary supplements, products may contain inaccurate dosages, contaminants, or undisclosed ingredients. Huberman’s recommendations direct millions of listeners into this unregulated market.
Authority bias: When a Stanford professor with a Ph.D. makes specific dosage recommendations, listeners are less likely to question those recommendations or consult their own physicians — even though the recommendations fall outside the professor’s area of expertise.
Alpha-GPC concerns: Huberman also recommends Alpha-GPC as a cognitive enhancer. A subsequent study found Alpha-GPC was associated with a 46% increased risk of stroke over 10 years in long-term users, due to increased TMAO levels in the blood.

What Huberman Gets Right

It is important to acknowledge that Huberman’s general advice on sleep hygiene — getting morning sunlight, keeping the room cool, avoiding screens before bed, managing body temperature — is largely consistent with mainstream sleep science. His discussion of fermented foods and gut microbiome health is grounded in legitimate Stanford research by Dr. Justin Sonnenburg. And his recommendation to get blood work done before and after starting supplements reflects a responsible caveat, even if it does not fully mitigate the concerns above.

The issue is not that everything Huberman says is wrong, but that his legitimate expertise and credentials lend unwarranted authority to specific supplement recommendations that lack adequate evidence and carry undisclosed financial conflicts.

Conclusion

JRE Episode 1683 illustrates the danger of the “credentialed expert outside their field” pattern. Andrew Huberman is a genuine, accomplished neuroscientist — but his expertise is in vision science, not endocrinology, supplement pharmacology, or herbal medicine. When he uses his Stanford credentials to recommend specific supplements at specific dosages to millions of listeners, particularly supplements with zero human clinical trials and documented organ toxicity in animal studies, the potential for harm is real. Rogan’s failure to question any of these claims, ask about conflicts of interest, or push back on the lack of human data makes this episode a case study in how scientific authority can be misapplied.